Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Overview
This document will help manufacturers prepare a submission for a notice of compliance for a COVID-19 drug under the Regulations. It also outlines the process for meeting the post-market regulatory requirements.
Organization:
Health Canada
Resource Formats:
- HTML